We found that the MASLD + OSA group had higher concentrations of TG (Fig. 4b) and cholesterol (Fig. 4c), liver weight (Fig. 4d), ALT and AST (Fig. 4e) compared with MASLD and Control groups. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.